Senseonics Holdings (NYSEAMERICAN:SENS) Director Douglas A. Roeder sold 980,389 shares of Senseonics stock in a transaction that occurred on Friday, June 15th. The shares were sold at an average price of $4.02, for a total transaction of $3,941,163.78. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website.
Shares of SENS traded down $0.07 during mid-day trading on Friday, reaching $4.91. 14,685,400 shares of the stock traded hands, compared to its average volume of 1,058,948. Senseonics Holdings has a 12-month low of $1.68 and a 12-month high of $5.29. The company has a current ratio of 2.93, a quick ratio of 2.81 and a debt-to-equity ratio of 0.76.
Senseonics (NYSEAMERICAN:SENS) last posted its quarterly earnings data on Thursday, May 10th. The company reported ($0.16) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.12) by ($0.04). The firm had revenue of $2.90 million for the quarter, compared to analysts’ expectations of $2.59 million. Senseonics had a negative net margin of 828.76% and a negative return on equity of 406.72%. The company’s quarterly revenue was up 480.0% compared to the same quarter last year. sell-side analysts anticipate that Senseonics Holdings will post -0.54 EPS for the current year.
Several institutional investors and hedge funds have recently bought and sold shares of SENS. Millennium Management LLC increased its stake in shares of Senseonics by 43.5% in the first quarter. Millennium Management LLC now owns 1,387,566 shares of the company’s stock worth $4,163,000 after buying an additional 420,358 shares during the last quarter. Element Capital Management LLC bought a new stake in shares of Senseonics in the first quarter worth $309,000. Tibra Equities Europe Ltd bought a new stake in shares of Senseonics in the first quarter worth $546,000. Glenmede Trust Co. NA increased its stake in shares of Senseonics by 84.6% in the fourth quarter. Glenmede Trust Co. NA now owns 200,387 shares of the company’s stock worth $533,000 after buying an additional 91,822 shares during the last quarter. Finally, California State Teachers Retirement System bought a new stake in shares of Senseonics in the fourth quarter worth $651,000. Institutional investors own 30.66% of the company’s stock.
Senseonics Company Profile
Senseonics Holdings, Inc, a medical technology company, designs, develops, and commercializes continuous glucose monitoring (CGM) systems for people with diabetes primarily in Europe. Its products include Eversense and Eversense XL, which are implantable CGM systems that is designed to continually and accurately measure glucose levels in people with diabetes for a period of up to 90 and 180 days.
Receive News & Ratings for Senseonics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Senseonics and related companies with MarketBeat.com's FREE daily email newsletter.